IFIH1 and neoplasm: Normally, RN7SL1 can be shielded from being recognized by PRR, but when it is not shielded, it can mimic viral RNA and activate nucleic acid sensors MDA5 and RIG-I, thus enhancing endogenous anti-tumor immunity (54, 56).